Increased expression and local accumulation of the Prion Protein, Alzheimer A peptides, superoxide dismutase 1, and Nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes

BMC Physiology

Volumn 10, Issue 1, 2010, Pages

  Bitel, Claudine L ^a,b   Feng, Yicheng ^a   Souayah, Nizar ^a   Frederikse, Peter H ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; DISEASE MODEL; GENE EXPRESSION; HUMAN; METABOLISM; MUSCLE; PRION; RABBIT;

AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; MUSCLES; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; PRIONS; RABBITS; SUPEROXIDE DISMUTASE;

EID: 77956463096     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-10-18     Document Type: Article

References (55)

1. Incidence and prevalence of diabetes mellitus in the Americas. A Barcelo S Rajpathak, Rev Panam Salud Publica 2001 10 5 300 308 11774801
2. Diabetic amyotrophy: a brief review. J Idiculla N Shirazi J Opacka-Juffry Ganapathi, Natl Med J India 2004 17 4 200 202 15372763
3. Muscular response and adaptation to diabetes mellitus. LL Sun Z N Liu Y Liu, Front Biosci 2008 13 4765 4794 10.2741/3038 18508544
4. Muscle compromise in diabetes. FFF Yildirim Donmez, Acta Radiol 2008 49 673 679 10.1080/02841850802105269 18568560
5. Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis. GO Chen X JD Geiger, Am J Physiol Regul Integr Comp Physiol 2008 294 829 835 18216139
6. Accumulation of prion protein in muscle fibers of experimental chloroquine myopathy: in vivo model for deposition of prion protein in non-neuronal tissues. H Furukawa K Doh-ura K Sasaki T Iwaki, Lab Invest 2004 84 7 828 835 10.1038/labinvest.3700111 15122307
7. Amyloid beta protein in rat soleus muscle in chloroquine-induced myopathy using end-specific antibodies for A beta 40 and A beta 42: immunohistochemical evidence for amyloid beta protein. K Tsuzuki R Fukatsu Y Takamaru T Yoshida Y Hayashi H Yamaguchi N Fujii N Takahata, Neurosci Lett 1995 202 1-2 77 80 10.1016/0304-3940(95)12205-2 8787835
8. Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms. V Askanas WK Engel, Curr Opin Neurol 2002 15 5 525 531 10.1097/00019052-200210000-00002 12351995
9. Increased expression of manganese superoxide dismutase is associated with that of nitrotyrosine in myopathies with rimmed vacuoles. Y Tsuruta A Furuta N Taniguchi T Yamada J Kira T Iwaki, Acta Neuropathol 2002 103 1 59 65 10.1007/s004010100428 11837748
10. Nitric oxide-induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies. CC Yang RB Alvarez WK Engel SL Heller V Askanas, Brain 1998 121 Pt 6 1089 1097 10.1093/brain/121.6.1089 9648544
11. Alzheimer's disease could be "type 3 diabetes". H Pilcher, Lancet Neurol 2006 5 5 388 389 10.1016/S1474-4422(06)70434-3 16639835
12. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. FG De Felice MN Vieira TR Bomfim H Decker PT Velasco MP Lambert KL Viola WQ Zhao ST Ferreira WL Klein, Proc Natl Acad Sci USA 2009 106 6 1971 1976 10.1073/pnas.0809158106 19188609
13. Amyloid beta oligomers induce impairment of neuronal insulin receptors. WQ Zhao FG De Felice S Fernandez H Chen MP Lambert MJ Quon GA Krafft WL Klein, FASEB J 2008 22 1 246 260 10.1096/fj.06-7703com 17720802
14. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. G Dobrowolny M Aucello E Rizzuto S Beccafico C Mammucari S Boncompagni S Belia F Wannenes C Nicoletti Z Del Prete N Rosenthal M Molinaro F Protasi G Fan M Sandri A Musar Cell Metab 2008 8 5 425 436 10.1016/j.cmet.2008.09.002 19046573
15. Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice. S Huang J Liang M Zheng X Li M Wang P Wang D Vanegas D Wu B Chakraborty AP Hays K Chen SG Chen S Booth M Cohen P Gambetti Q Kong, Proc Natl Acad Sci USA 2007 104 16 6800 6805 10.1073/pnas.0608885104 17420473
16. Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis. LW Jin MG Hearn CE Ogburn N Dang D Nochlin WC Ladiges GM Martin, Am J Pathol 1998 153 6 1679 1686 9846957
17. Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. M Kitazawa KN Green A Caccamo FM LaFerla, Am J Pathol 2006 168 6 1986 1997 10.2353/ajpath.2006.051232 16723713
18. Transgenic expression of beta-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology. CE Moussa Q Fu P Kumar A Shtifman JR Lopez PD Allen F LaFerla D Weinberg J Magrane T Aprahamian K Walsh KM Rosen HW Querfurth, FASEB J 2006 20 12 2165 2167 10.1096/fj.06-5763fje 16940437
19. Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model. MC Sugarman M Kitazawa M Baker VJ Caiozzo HW Querfurth FM LaFerla, Neurobiol Aging 2006 27 3 423 432 10.1016/j.neurobiolaging.2005.02.011 15950323
20. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. CS Atwood RC Scarpa X Huang RD Moir WD Jones DP Fairlie RE Tanzi AI Bush, J Neurochem 2000 75 3 1219 1233 10.1046/j.1471-4159.2000.0751219.x 10936205
21. Normal prion protein has an activity like that of superoxide dismutase. DR Brown BS Wong F Hafiz C Clive SJ Haswell IM Jones, Biochem J 1999 344 Pt 1 1 5 10.1042/0264-6021:3440001 10548526
22. Metals and neuroscience. AI Bush, Curr Opin Chem Biol 2000 4 2 184 191 10.1016/S1367-5931(99)00073-3 10742195
23. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). C Opazo X Huang RA Cherny RD Moir AE Roher AR White R Cappai CL Masters RE Tanzi NC Inestrosa AI Bush, J Biol Chem 2002 277 43 40302 40308 10.1074/jbc.M206428200 12192006
24. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. J Miklossy H Qing A Radenovic A Kis B Vileno F Laszlo L Miller RN Martins G Waeber V Mooser F Bosman K Khalili N Darbinian PL McGeer, Neurobiol Aging 2008 31 1503 1515 10.1016/j.neurobiolaging.2008.08.019 18950899
25. Thiamine deficiency in vivo produces fiber cell degeneration in mouse lenses. PH Frederikse P Farnsworth JS Zigler Jr, Biochem Biophys Res Commun 1999 258 3 703 707 10.1006/bbrc.1999.0560 10329449
26. Mechanistic insights into diabetes mellitus and oxidative stress. K Maiese ZZ Chong YC Shang, Curr Med Chem 2007 14 16 1729 1738 10.2174/092986707781058968 17627510
27. Advanced glycation end products and insulin resistance. H Unoki S Yamagishi, Curr Pharm Des 2008 14 10 987 989 10.2174/138161208784139747 18473850
28. Role for IKK2 in muscle: waste not, want not. M Karin, J Clin Invest 2006 116 11 2866 2868 10.1172/JCI30268 17080193
29. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. E Kefaloyianni C Gaitanaki I Beis, Cell Signal 2006 18 12 2238 2251 10.1016/j.cellsig.2006.05.004 16806820
30. Exercise, MAPK, and NF-kappaB signaling in skeletal muscle. HF Kramer LJ Goodyear, J Appl Physiol 2007 103 1 388 395 10.1152/japplphysiol.00085.2007 17303713
31. Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. PH Frederikse D Garland JS Zigler Jr J Piatigorsky, J Biol Chem 1996 271 17 10169 10174 10.1074/jbc.271.17.10169 8626578
32. Prion protein expression in mammalian lenses. PH Frederikse SJ Zigler Jr PN Farnsworth DA Carper, Curr Eye Res 2000 20 2 137 143 10617916
33. A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's beta-amyloid precursor protein gene. J Trejo T Massamiri T Deng NN Dewji RM Bayney JH Brown, J Biol Chem 1994 269 34 21682 21690 8063812
34. Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease. JB Standridge, Curr Alzheimer Res 2006 3 2 95 108 10.2174/ 156720506776383068 16611010
35. The mechanisms of alloxan- and streptozotocin-induced diabetes. S Lenzen, Diabetologia 2008 51 2 216 226 10.1007/s00125-007-0886-7 18087688
36. The relationship between the physicochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives. R Munday K Ludwig S Lenzen, J Endocrinol 1993 139 1 153 163 10.1677/joe.0.1390153 8254288
37. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. T Szkudelski, Physiol Res 2001 50 6 537 546 11829314
38. Effect of alloxan-diabetes on the metabolism of rabbit colon smooth muscle. HJ Arnqvist, Acta Physiol Scand 1975 93 4 500 504 10.1111/j.1748-1716. 1975.tb05841.x 1155143
39. Morphological study on alloxan-induced cataract. CL Von Sallmann L P Grimes EM Collins, AMA Arch Ophthalmol 1958 59 55 67 13486993
40. Asparagine-linked glycosylation of the scrapie and cellular prion proteins. T Haraguchi S Fisher S Olofsson T Endo D Groth A Tarentino DR Borchelt D Teplow L Hood A Burlingame E Lycke SB Prusiner, Arch Biochem Biophys 1989 274 1 1 13 10.1016/0003-9861(89)90409-8 2505674
41. Expression of the APP gene family in brain cells, brain development and aging. R Sandbrink U Monning CL Masters K Beyreuther, Gerontology 1997 43 1-2 119 131 10.1159/000213840 8996834
42. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. DA Wink JB Mitchell, Free Radic Biol Med 1998 25 4-5 434 456 10.1016/S0891-5849(98)00092-6 9741580
43. A genetic analysis of nitrosative stress. MW Foster L Liu M Zeng DT Hess JS Stamler, Biochemistry 2009 48 4 792 799 10.1021/bi801813n 19138101
44. Nitric oxide and neurological disorders. AJ Duncan SJ Heales, Mol Aspects Med 2005 26 1-2 67 96 10.1016/j.mam.2004.09.004 15722115
45. Toward structural elucidation of the gamma-secretase complex. H Li MS Wolfe DJ Selkoe, Structure 2009 17 3 326 334 10.1016/j.str.2009.01.007 19278647
46. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. J Lauren DA Gimbel HB Nygaard JW Gilbert SM Strittmatter, Nature 2009 457 7233 1128 1132 10.1038/nature07761 19242475
47. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. SH Lecker RT Jagoe A Gilbert M Gomes V Baracos J Bailey SR Price WE Mitch AL Goldberg, FASEB J 2004 18 1 39 51 10.1096/fj.03-0610com 14718385
48. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. JM Sacheck JP Hyatt A Raffaello RT Jagoe RR Roy VR Edgerton SH Lecker AL Goldberg, FASEB J 2007 21 1 140 155 10.1096/fj.06-6604com 17116744
49. DNA damage by nitric oxide. S Tamir S Burney SR Tannenbaum, Chem Res Toxicol 1996 9 5 821 827 10.1021/tx9600311 8828916
50. DNA damage and genotoxicity by nitric oxide. S Tamir T deRojas-Walker JS Wishnok SR Tannenbaum, Methods Enzymol 1996 269 230 243 full-text 8791653
51. DNA damage induced by peroxynitrite: subsequent biological effects. C Szabo H Ohshima, Nitric Oxide 1997 1 5 373 385 10.1006/niox.1997.0143 9441908
52. The chemistry of DNA damage from nitric oxide and peroxynitrite. S Burney JL Caulfield JC Niles JS Wishnok SR Tannenbaum, Mutat Res 1999 424 1-2 37 49 10064848 (Pubitemid 29101606)
53. Nitric oxide: a review of its role in retinal function and disease. IM Goldstein P Ostwald S Roth, Vision Res 1996 36 18 2979 2994 10.1016/0042- 6989(96)00017-X 8917798
54. Poly (ADP-ribose) polymerase, nitric oxide and cell death. AA Pieper A Verma J Zhang SH Snyder, Trends Pharmacol Sci 1999 20 4 171 181 10.1016/S0165-6147(99)01292-4 10322503
55. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. Y Du MA Smith CM Miller TS Kern, J Neurochem 2002 80 5 771 779 10.1046/j.0022-3042.2001.00737.x 11948240